These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 23636010)
41. Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease. Ram CV Future Cardiol; 2009 Sep; 5(5):453-65. PubMed ID: 19715410 [TBL] [Abstract][Full Text] [Related]
42. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension]. Burnier M Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386 [TBL] [Abstract][Full Text] [Related]
43. Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation. Ducharme A; Schiffrin EL Can J Cardiol; 2010 Dec; 26 Suppl E():21E-23E. PubMed ID: 21620287 [TBL] [Abstract][Full Text] [Related]
44. Tissue renin-angiotensin systems. Their role in cardiovascular disease. Lee MA; Böhm M; Paul M; Ganten D Circulation; 1993 May; 87(5 Suppl):IV7-13. PubMed ID: 8485836 [TBL] [Abstract][Full Text] [Related]
45. Hepatic fibrosis and the renin-angiotensin system. Abbas G; Silveira MG; Lindor KD Am J Ther; 2011 Nov; 18(6):e202-8. PubMed ID: 20535005 [TBL] [Abstract][Full Text] [Related]
46. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step? Hollenberg NK Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314 [TBL] [Abstract][Full Text] [Related]
47. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. Jensen J; Henik RA; Brownfield M; Armstrong J Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564 [TBL] [Abstract][Full Text] [Related]
48. The evolution of angiotensin blockade in the management of cardiovascular disease. Nantel P; René de Cotret P Can J Cardiol; 2010 Dec; 26 Suppl E():7E-13E. PubMed ID: 21620285 [TBL] [Abstract][Full Text] [Related]
49. Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease. Goh GB; Pagadala MR; Dasarathy J; Unalp-Arida A; Sargent R; Hawkins C; Sourianarayanane A; Khiyami A; Yerian L; Pai R; McCullough AJ; Dasarathy S Liver Int; 2015 Mar; 35(3):979-85. PubMed ID: 24905085 [TBL] [Abstract][Full Text] [Related]
50. The renin-angiotensin system in essential hypertension: associations with cardiovascular risk. Allikmets K; Parik T; Viigimaa M Blood Press; 1999; 8(2):70-8. PubMed ID: 10451033 [TBL] [Abstract][Full Text] [Related]
51. The role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndrome. Sharma AM; Engeli S J Cardiometab Syndr; 2006; 1(1):29-35. PubMed ID: 17675902 [TBL] [Abstract][Full Text] [Related]
52. Platelet activation during exercise is not attenuated by inhibition of the renin-angiotensin system: the role of physical activity. Petidis K; Grammatiki M; Doumas M J Hypertens; 2013 Oct; 31(10):2103. PubMed ID: 24107739 [No Abstract] [Full Text] [Related]
53. Platelet activation during exercise is not attenuated by inhibition of the renin angiotensin system: the role of physical activity. Kahan T; Schwieler JH; Wallén H; Nussberger J; Hjemdahl P J Hypertens; 2013 Oct; 31(10):2103-4. PubMed ID: 24107740 [No Abstract] [Full Text] [Related]
54. Development of albuminuria and enhancement of oxidative stress during chronic renin-angiotensin system suppression. Ruiz-Hurtado G; Condezo-Hoyos L; Pulido-Olmo H; Aranguez I; Del Carmen Gónzalez M; Arribas S; Cerezo C; Segura J; Praga M; Fernández-Alfonso MS; Ruilope LM J Hypertens; 2014 Oct; 32(10):2082-91; discussion 2091. PubMed ID: 25033166 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of the cerebral renin-angiotensin system to limit cognitive decline in elderly hypertensive persons. Opie LH Cardiovasc Drugs Ther; 2011 Aug; 25(4):277-9. PubMed ID: 21773690 [TBL] [Abstract][Full Text] [Related]
56. The renin-angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease. Volpe M; Savoia C; De Paolis P; Ostrowska B; Tarasi D; Rubattu S J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S173-8. PubMed ID: 12466309 [TBL] [Abstract][Full Text] [Related]
57. Exercise-induced platelet activation in essential hypertension: have we solved the puzzle? Gkaliagkousi E; Gavriilaki E; Nikolaidou B; Douma S J Hypertens; 2013 Sep; 31(9):1915-6. PubMed ID: 24107673 [No Abstract] [Full Text] [Related]
58. Exercise-induced platelet activation in essential hypertension: have we solved the puzzle? Reply. Kahan T; Schwieler JH; Wallén H; Nussberger J; Hjemdahl P J Hypertens; 2013 Sep; 31(9):1917. PubMed ID: 24107674 [No Abstract] [Full Text] [Related]
59. The protective arms of the renin-angiontensin system in stroke. McCarthy CA; Facey LJ; Widdop RE Curr Hypertens Rep; 2014 Jul; 16(7):440. PubMed ID: 24816974 [TBL] [Abstract][Full Text] [Related]
60. Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients. Alderman MH; Cohen HW; Sealey JE; Laragh JH Am J Hypertens; 2004 Jan; 17(1):1-7. PubMed ID: 14700504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]